Table 1 Description of the patients involved in the study
From: Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Patient | Gender | Age | Country of origin | CDC class | Previous ART regimen | New ART regimen | Reason for ART switch | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|
1 | F | 18 | Italy | 3 | LPV/r + TDF/FTC | DTG + TDF/FTC | Side effects Low adherence | 24 |
2 | F | 17 | Nigeria | 3 | LPV/r + TDF/FTC | DTG + TDF/FTC | Side effects Low adherence | 24 |
3 | M | 12 | Italy | 3 | LPV/r + ABC + 3TC | DTG/ABC/3TC | Side effects | 24 |
4 | M | 16 | Italy | 1 | LPV/r + TDF/FTC | DTG + TDF/FTC | Side effects Low adherence | 24 |
5 | F | 18 | Nigeria | 3 | FPV + TDF/FTC + ATV + RTV | DTG + TDF/FTC | ART simplification | 12 |
6 | F | 17 | Ukraine | 3 | EFV + FTC + TDF | DTG/ABC/3TC | Side effects Low adherence | 9 |